共 50 条
- [33] Humira® (Adalimumab) Approved in Europe for the treatment of Moderate-Severe Crohn's disease VISZERALMEDIZIN, 2012, 28 (05): : 356 - 356
- [36] Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe PLOS ONE, 2020, 15 (01):
- [37] DTI-derived parameters differ between moderate and severe traumatic brain injury and its association with psychiatric scores Neurological Sciences, 2022, 43 : 1343 - 1350